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the trends for cemented and uncemented fixation technique until 2021 by linear
regression. A dynamic Markov model with a cycle length of one year and time
frame of 10 years was developed to calculate the number of revisions and costs
from a hospital resource-use perspective. Patients enter the model after primary
THA and can progress to septic or aseptic revision and death. The transmission
probabilities were derived from Scandinavian registry studies. Hospital costs were
taken from published literature about resource utilization in England and were
discounted by 3% annually. RESULTS: An annual increase of 3,960 THAs (R-square,
0,87) was observed during the period. The share of uncemented THAs increased
from 20,2% in 2004 to 42,2% in 2008 with an annual increase of 3,707 uncemented
THAs (R-square, 0,99). The proportion of cemented THAs decreased steadily. A
continuation of this trend would lead to hospital costs of £7,246 million and 16193
revisions over a 10 year period. A reversal of this trendwould lead to costs of £7,176
million and 14980 revisions, resulting in savings of £69,8million and the avoidance
1212 revisions. CONCLUSIONS: The results suggest that the current trend towards
uncemented fixation of THAs is unjustified. A shift towards cemented fixation
technique should be considered.
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COST-EFFECTIVENESS OF PRIMARY PCI WITHOUT ONSITE SURGICAL BACKUP
Ramos P
University of Louisville, Louisville, KY, USA
OBJECTIVES: The American College of Cardiologists and the American Heart Asso-
ciation strongly recommend that a hospital performing PCI must also have coro-
nary artery bypass graft capabilities. Following these recommendations, the state
of Kentucky has limited the number of hospitals allowed to perform PCI and
thereby limiting access to this life-saving procedure. Recently, the state of Ken-
tucky evaluated if hospitalswithout such capabilities should be allowed to perform
primary PCI. The resulting data allowed the establishment of the medical sound-
ness of allowing such hospitals to perform primary PCI. The current study aims to
evaluate the financial feasibility of allowing these hospitals to do emergency PCI in
addition to hospitals with onsite open-heart surgery capabilities.METHODS: Esti-
mates have been derived from a systematic literature review of national studies
based on PCI registries as well as our earlier study - KENTUCKY PILOT PROJECT FOR
PRIMARY PCI WITHOUT ONSITE CABG. Costs estimates were derived from the Na-
tional Inpatient Sample. In determining costs, the observations were extracted by
filtering using ICD-9 codes using SAS. A deterministic model, implemented in Mi-
crosoft Excel, was developed so that more uncertainty would not be introduced.
The evaluation estimated the incremental cost effectiveness ratio (ICER) of allow-
ing regional hospitals to perform primary PCI from a payer’s perspective. Uncer-
tainty about the model parameters was investigated through sensitivity analysis.
RESULTS:The study found that therewere no statistically significant differences in
outcomes between hospitals with and without CABG capabilities. The only char-
acteristic, which was significantly different between these two groups, was total
charges. The alternative to allow Regional Hospitals as well to perform primary PCI
dominated the other alternative of Only Allowing Hospitals with Onsite CABG to per-
form PCI. CONCLUSIONS: States, such as Kentucky, that strictly follow the AHA/
ACC recommendations about PCI should consider the cost-effectiveness evidence
when making public policy.
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OBJECTIVES: To estimate the impact of radiofrequency ablation (RFA) on short and
long-term healthcare utilization and expenditures in general and Medicare popu-
lations with AF.METHODS:We analyzed data from the USMarketScan® Commer-
cial Claims and Encounters Database and Medicare Supplemental Database from
Thomson Reuters. The databases are comprised of de-identified patient-level re-
cords from employer-sponsored and public health insurance plans. We used a
coding algorithm to identify 3,194 patients with an RFA procedure for treatment of
AF, who had continuous enrollment in the database 6 months prior to their first
ablation, and aminimumof one year follow-up post ablation. Multivariable regres-
sion models for utilization and expenditures were built for all patients, and sub-
analyses were performed for patients 65-years and over. Results are reported for
five samples, based on duration of available follow-up: 12 months, 18 months, 2
years, 2.5 years, and 3 years post ablation. RESULTS: Compared to the six months
prior to RFA, therewere significant reductions in the number of outpatient appoint-
ments, hospital inpatient days, and emergency room visits in the total study pop-
ulation as well as the subset of patients 65 and older. There was a statistically
significant (p.01) decrease in total expenditures (insurer and patient out-of-
pocket expenditures) across all five time periods, with average savings of approx-
imately $5,000 over each six month period after ablation ($800 per month). For
patients 65 and over, the average savings were approximately $700 per month.
Drug utilization also significantly declined (p.05), with average savings in
medication expenditures ranging from $317 to $578 per 6 month period. The
reduction in drug utilization was durable and significant in patients 65 and over.
CONCLUSIONS: RFA for AF reduces real-world healthcare utilization and expendi-
tures up to 3 years post ablation. This reductionwas consistent, significant, andhas
implications for both general and Medicare populations.
Surgery – Patient-Reported Outcomes & Preference-Based Studies
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OBJECTIVES: Non-adherence to medication regimens after organ transplantation
is a major risk factor for acute rejection and graft loss, however, there is limited
data quantifying the associated risk. This study examines the association between
adherence to immunosuppressant therapy and rejection in liver and kidney organ
transplant recipients. METHODS: This is a randomized, cross sectional analysis.
Adherence to immunosuppressants was assessed by administering the Immuno-
suppresive Therapy Adherence Scale (ITAS) to patients at the time of their clinic
appointment. Rejection was defined as biopsy proven rejection. The number of
biopsies, number of rejections, rejection severity and length of hospital stay due to
rejection were collected. Immunosuppressant regimens, levels, number of dose
changes, and number of tablets/capsules per day were obtained. Logistic regres-
sion model was used to determine the association between rejection and adher-
ence, gender and number of tablets/capsules consumed per day. RESULTS: A total
of 67 patients were included in this study, from which 21(31%) were males with an
average age of 51 years, SD11.6. There were 49 (73.1%) kidney recipients, 14
(20.9%) liver recipients and 4 (5.9%) combination. At least one rejection was ob-
served in 26 (38.8%) of the patients, from which 18 (69.2%), 6 (23.1%) and 2 (7.7%)
were kidney, liver and combination, respectively. A total of 35 (52.3%) of the pa-
tients were found to be non-adherent with their medications, from which 18
(51.4%) had at least one rejection. Patients were taking an average of 18 tablets/
capsules per day. The logistic regression showed that gender and tablets/capsules
consumed per day had no impact on rejection, however, non-adherence is signif-
icantly associated with rejection (OR0.264, 95% CI is 0.089-0.784). Non adherent
patient are 74% more likely to have a rejection compared to adherent patients.
CONCLUSIONS: Non-adherence to immunosuppressive medication results in in-
creased rejection rates in kidney and liver transplant recipients.
PSU13
MORBID OBESITY AND HEALTH RELATED QUALITY OF LIFE
Tayyem R1, Ali A2, Atkinson J3, Martin CR4
1Whittington Hospital, London, UK, 2The Ayr Hospital, Ayr, UK, 3University of the West of
Scotland, Paisley, UK, 4University of the West of Scotland, Ayr, UK
OBJECTIVES: Significant health risks impact on individuals with morbid obesity
including deleterious effects on health related quality of life (HRQOL). A mono-
centric prospective studywas conducted to evaluate the impact of bariatric surgery
and morbid obesity on HRQOL. METHODS: Data were collected from 236 partici-
pants: 83 patients who were under consideration for bariatric surgery, 68 patients
who already have had a bariatric procedure and 85 volunteers. Participants were
asked to complete Bariatric and Obesity Specific Survey (BOSS), Short Form Health
survey (SF-36), Hospital Anxiety and Depression (HADS) scale, Moorehead-Ardelt
Quality of life Questionnaire (M-A QoLQ II), and a demographic data sheet.
RESULTS: Obese people displayed lower levels of HRQOL compared to non-obese
people with an almost linear negative relationship between bodymass index (BMI)
and HRQOL. Obese females with BMI between 30 and 40 were more susceptible to
the adverse effects of obesity compared to males, particularly in the domains of
“Incapacity” and “Sexual Health”. There was no statistically significant HRQOL
difference, however, between men and women in the non obese (BMI  30) and
morbid obesity (BMI 40). “Appearance and Health” and “Sexual Health” domains
were comparable between patients who had surgery and the control group.
CONCLUSIONS: Females are more susceptible to the adverse effects of weight
compared tomales up to certainweight level afterwhich gender equity in adversity
becomes the norm. The domains of “Appearance and Health” and “Sexual Health”
are the quickest domains that will recover from the negative impact of obesity
following bariatric surgery.
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OBJECTIVES: Studies on health-related quality of life (HRQoL) of patients on kidney
transplant waiting list remained scarce despite the fact that it can predict future
morbidity andmortality. The aims of the studywere therefore tomeasure theHRQoL
of patients on kidney transplant waiting list compared with that of the general popu-
lation, to identify non-disease factorswhich could impact on theHRQoL scores and to
evaluate the reliability of the SF-36 in this group of patients.METHODS: This was a
cross-sectional study of kidney transplant waiting list patients managed at a ter-
tiary renal unit in Singapore using the SF-36. A SF-36 normative calculator gener-
ated HRQoL scores for a matched cohort of the Singapore general population. Re-
liability of SF-36 was assessed by Cronbach’s alpha coefficients. RESULTS: There
were 265 respondents. Our study shows that HRQoL scores for patients on kidney
transplant waiting list were lower than the population norms across all subscales
and were clinically significant for General Health, Role Physical, Bodily Pain, Social
Functioning and Mental Component Summary scores. Non-disease factors like
being Chinese, married, employed, undergoing haemodialysis and not being of-
fered a living kidney donation predicted better HRQoL scores after adjusting for
possible confounders. Age, gender, educational level, household income, history of
kidney transplant, duration on transplant waiting list and years on dialysis did not
significantly influence SF-36 across all subscales scores. Seven of 8 subscales in
A88 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 1 – A 2 1 4
SF-36 had acceptable reliability of Cronbach alpha values of 0.7. CONCLUSIONS:
Patients on kidney transplant waiting list had worse HRQoL than the general pop-
ulation. More research could be done into reasons for poorer HRQoL among the
at-risk patients. SF-36 was a reliable tool in assessing the HRQoL of patients on
kidney transplant waiting list in Singapore.
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OBJECTIVES: There is a lack of a psychometrically robust bariatric-specific health
related quality of life (HRQOL) tool. A mono-centric prospective study was con-
ducted to develop and validate a new bariatric specific 81-item self report HRQOL
instrument called the Bariatric and Obesity Surgery Survey (BOSS). METHODS:
Data were collected from 236 participants: 83 patients who were under consider-
ation for bariatric surgery, 68 patients who already have had a bariatric procedure
and 85 volunteers. Participants were also required to complete the Short Form
Health survey (SF-36), Hospital Anxiety and Depression (HADS) scale, Moorehead-
Ardelt Quality of life Questionnaire (M-A QoLQ II), and a demographic data sheet.
Two weeks following the completion of these 5 questionnaires, participants were
asked to complete BOSS once more along with a feedback sheet. RESULTS: Explor-
atory factor analysis revealed a multidimensional instrument consisting of 42
items distributed over 6 domains that address various HRQOL aspects and dimen-
sions pertinent to bariatric surgery, and relevant to morbidly obese patients. Fur-
ther psychometric analysis showed that BOSS has adequate internal consistency
reliability (Cronbach   0.970), test re-test reliability (ICC  0.926), construct va-
lidity, criterion validity, face validity and acceptability. CONCLUSIONS: BOSS is a
valid and reliable multidimensional instrument that provides a clinically useful
and relevant measure to assess HRQoL in patients undergoing bariatric surgery.
Surgery – Heath Care Use & Policy Studies
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OBJECTIVES: To compare the incidence of post-operative complications, health-
care utilization, and costs in laparoscopic supracervical hysterectomy (LSH) versus
laparoscopic-assisted vaginal hysterectomy (LAVH) patients. METHODS: Women
18 years with LSH or LAVH from 1/1/2007 - 9/30/ 2008 were identified in the
Thomson Reuters MarketScan® Commercial Claims and Encounter Database. Pa-
tients were required to have 6 months of continuous medical and prescription
coverage prior and subsequent to the hysterectomy date. Patients were excluded if
they had a diagnosis of cancer, had index date procedure codes for both LSH and
LAVH, or if the length of stay associated with the index procedure exceeded 20
days. Post-operative outcomes and gynecologic-related (GYN-related) utilization
and costs were measured 30 and 180 days post-surgery. Multivariate analysis was
conducted to compare post-surgical outcomes and costs between patients with
LSH and LAVH controlling for demographic and clinical characteristics. RESULTS:
A total of 6,198 LSH patients and 14,181 LAVH patients met the study criteria.
Compared with the LAVH cohort, LSH patients were more likely to have dysfunc-
tional uterine bleeding (32.6% vs. 27.9%) and leiomyomas (38.0% vs. 26.3%) as their
primary diagnosis and less likely to have endometriosis (9.3% vs. 10.4%) and pro-
lapse (1.5% vs. 8.0%), p0.01 in all cases; had significantly lower overall infection
rates (6.2% vs. 7.4%, p0.002); and had significantly lower total GYN-related costs
($252 vs. $385, p0.001, 30 days post-surgery; $350 vs. $569, p0.001, 180 days post-
surgery). After multivariate adjustment for patient characteristics, total costs were
estimated to be $108 and $174 lower for LSHpatients than for LAVHpatientswithin 30
and 180 days of follow up, respectively (p0.001). LSH patients had significantly lower
hazards of developing infection (hazard ratio [HR]0.830), hematologic complication
(HR0.667), and analgesic use (HR0.812). CONCLUSIONS: LSH patients demon-
strated fewer post-operative infections and lower GYN-related costs compared to
LAVH patients.
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OBJECTIVES: To examine the variation in outlier payments across U.S. hospitals
and the extent to which the variation is explained by patient and hospital factors,
including quality of care.METHODS:Using the National Medicare Claims database
for 2002, we examined outlier payments in patients undergoing coronary artery
bypass grafting (CABG) (n165,226), lower extremity bypass surgery (n43,886) and
colectomy (n101,345). We then categorized hospitals performing these proce-
dures according to their outlier payment rates. Using multiple logistic regression,
we explored the relationships between hospital outlier payment rates, patient case
mix and hospital quality, as reflected by risk-adjusted mortality rates. RESULTS:
For all three procedures, the proportion of patients associated with outlier pay-
ments varied from 10% (colectomy) to 14% (CABG). Average outlier payments were
considerable, ranging from$18,000 to over $24,000 per patient. Themost consistent
risk factors for outlier payments included race and admission acuity. Higher hos-
pital and surgeon volumes and teaching status were associated with lower rates of
outlier payments. There was a negative correlation between risk-adjusted mortal-
ity rates and outlier payments. For all three procedures, the proportion of outlier
payments varied widely across hospitals from less than 5% to greater than 20%.
Measurable patient and hospital factors explained a small proportion of variation
across hospitals.CONCLUSIONS:Outlier payments are an important component of
medical costs for inpatient surgery. Although explained in part by quality, the
reasons for a wide variation in outlier payments across hospitals remain to be
clarified.
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OBJECTIVES: 1. Examine the impact of insurance on treatment of localized
breast cancer using Breast Conserving Surgery (BCS) with radiation. 2. Identify
factors that contribute to women’s receiving breast conserving surgery with
radiation. METHODS: Breast cancer cases diagnosed during 1997-2002 were ob-
tained from the Florida Cancer Data System. Women aged 40 and above with lo-
calized breast cancer were included. Demographic, insurance, and treatment in-
formation were extracted and linked with 2000 Census data to get tract-level
information on education and poverty level. Multi-level logistic regression analysis
was conducted to determine factors that have contributed to BCS with radiation
treatment.RESULTS: 41,508womenwere diagnosedwith localized breast cancer in
Florida during 1997-2002. The study found that BCS without radiation andmastec-
tomywere the twomajor treatments for localized breast cancer. The average age of
the women was 66 years with 8.5% of them receiving BCS with radiation. Women
with the following characteristics were more likely to receive BCS with radiation
than their counterparts: having private or Medicare insurance, being married, liv-
ing in neighborhood with higher percentage of high school education, and being
recently diagnosed. CONCLUSIONS: Although BCS with radiation is recommended
to treat women with localized breast cancer by clinical practice guidelines and the
use of this treatment has significantly increased over time, there are still differ-
ences in receiving the treatment among women with different health insurance
and marital status. Possible reasons for the differences require further research.
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STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASIS
Jung SY, Hwang JS, Choi JE, Shin SY, Kim JH, Hyun MK, Kim YE, Bae JM
National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea
OBJECTIVES: To assess the pattern of radiotherapy and radiosurgery for newly
diagnosed and recurred brain metastasis. METHODS: Using the Korean Health
Insurance Review&Assessment Service (HIRA) claims database, patientswho aged
20 or more, diagnosed as brain metastasis (ICD 10 C79.3) during January 1st, 2006
and June 30th, 2008, treated whole brain radiotherapy (WBRT) or stereotactic ra-
diosurgery (SRS), and without history of brain metastasis diagnosis or treatment
within 6months prior to index treatmentwere identified.With a permissible gap of
30 days, each treatment episodes were defined. The episodes were categorized as
those for newly diagnosed and recurrent brainmetastasis patients. Characteristics
of patients, frequency of WBRT/ SRS as initial and recurrence treatment, and the
mean number of re-treatment were analyzed. RESULTS: A total of 7,449 newly
treated patients and 2,008 recurrent patients satisfied the selection criteria. Among
new patients, 4,797 (64.4%) treated WBRT, 1,439 (19.3%) treated SRS, and 1,213
(16.3%) treated WBRT with SRS. Most frequent primary tumor was lung cancer
(57.2%). Recurrence rate of the new patients was 27.0%. Mean number of re-treat-
ment of WBRT or SRS was 1.38. Among patients who treated WBRT and SRS as
initial treatments, 69.8% and 50.2% treated the same treatment as first treatment
for recurrence, respectively. CONCLUSIONS: While clinical guidelines for brain
metastasis recommends WBRT with SRS for brain metastasis patients with favor-
able functional status, the proportion ofWBRTwith SRSwas relatively low. Further
research to explore the reason of the gap between evidence and real practice is
needed.
Surgery – Research on Methods
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IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?
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OBJECTIVES: Observational study is difficult to interpret due to a number of meth-
odological issues; cohort effects, the learning curve of the health care provider and
confounding by indication: This large scale retrospective study is aimed to ascer-
tain that there are indication bias of LASIK surgery between local hospital and
tertiary hospital in South Korea.METHODS: A retrospective cohort for consecutive
3,401 eyes received LASIK in 6 multicenter including tertiary hospital and local
hospital from 2002 to 2005 were registered. Sociodemographic, operation charac-
teristics, preoperative baseline manifest refractions (MR) and additional follow up
data at 3month, 6month and 12 month after surgery were collected. We used
independent t-test to compare preoperative difference between tertiary hospital
and local hospital and generalized linear mixed model with random intercept to
test characteristic of hospital and follow up time might influence to MR after
surgery. RESULTS:The baselineMR (meanSD) of tertiary hospital was5.242.07
and that of local hospital was 4.271.71 (p0.001). The mean MR at 3 month, 6
month and 12 month of tertiary hospital were 0.460.70, 0.550.69 and
A89V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 1 – A 2 1 4
